公司概覽
業務類別 Medical Devices
業務概覽 Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
公司地址 300 Boston Scientific Way, Marlborough, MA, USA, 01752-1234
電話號碼 +1 508 683-4000
傳真號碼 +1 508 650-8923
公司網頁 https://www.bostonscientific.com
員工數量 59000
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Ms. Miriam O’Sullivan Senior Vice President and Chief Human Resources Officer -- 19/03/2025
Mr. Vance R. Brown Senior Vice President, General Counsel, Corporate Secretary -- 19/03/2025
Mr. Jonathan R. Monson Executive Vice President and Chief Financial Officer -- 17/02/2026
Mr. Joseph M. Fitzgerald Executive Vice President and Group President, Cardiology 美元 842.36K 19/03/2025
Mr. Michael F. Mahoney Chairman of the Board, President and Chief Executive Officer 美元 1.40M 17/02/2026
Mr. John Bradley Sorenson Executive Vice President, Global Operations -- 19/03/2025
Mr. Arthur C. Butcher Executive Vice President and Group President, MedSurg and Asia Pacific 美元 708.88K 19/03/2025
Ms. Emily M. Woodworth Senior Vice President, Global Controller and Chief Accounting Officer -- 17/02/2026
 
董事會成員
董事會 職務 更新日期
Mr. Edward J. Ludwig Lead Independent Director 17/02/2026
Mr. David S. Wichmann Independent Director 17/02/2026
Ms. Ellen M. Zane Independent Director 17/02/2026
Mr. Yoshiaki Fujimori Independent Director 05/02/2026
Senator John E. Sununu Independent Director 17/02/2026
Ms. Susan E. Morano Independent Director 17/02/2026
Mr. Michael F. Mahoney Chairman of the Board, President and Chief Executive Officer 17/02/2026
Dr. Jessica L. Mega, M.D.,M.P.H. Independent Director 17/02/2026
Mr. David C. Habiger Independent Director 17/02/2026
Mr. Christophe Pierre Weber Director 23/02/2026
Ms. Catherine R. Smith Director 23/02/2026
Dr. Cheryl B. Pegus, M.D. Independent Director 17/02/2026
 
所屬ETF (更新日期: 07/03/2026 02:33)
代號 名稱 佔比% 持有日期
VFMVVanguard US Minimum Volatility ETF0.001%31/12/2025
GSGOGoldman Sachs Growth Opportunities ETF0.001%27/02/2026
SPXTProShares S&P 500® ex-Technology0.001%27/02/2026
RSPAInvesco S&P 500 Eq Wght Inc Adv ETF0.001%27/02/2026
KNOAXS Knowledge Leaders ETF0.001%27/02/2026
USNZXtrackers Net Zero Pwy Par Alg US Eq ETF0.001%26/02/2026
GVLEGoldman Sachs Value Opportunities ETF0.001%27/02/2026
TALVTransamerica Large Value Active ETF0.001%26/02/2026
CFOVictoryShares US 500 Enh Vol Wtd ETF0.001%27/02/2026
MFSGMFS Active Growth ETF0.001%27/02/2026
DTECALPS Disruptive Technologies ETF0.001%27/02/2026
CRTCXtrackers US National Crtcl Techs ETF0.001%26/02/2026
OALCOneAscent Large Cap Core ETF0.001%27/02/2026
PBPInvesco S&P 500 BuyWrite ETF0.001%27/02/2026
GURUGlobal X Guru™ ETF0.001%27/02/2026
GINNGoldman Sachs Innovate Equity ETF0.001%27/02/2026
FNDBSchwab Fundamental U.S. Broad Market ETF0.001%28/02/2026
SPINState Street® US Equity Premium Inc ETF0.001%27/02/2026
FADFirst Trust Multi Cap Gr AlphaDEX® ETF0.001%26/02/2026
FTQIFirst Trust Nasdaq BuyWrite Income ETF0.0005%26/02/2026
  1    2    3    4    5    6    7    8    9   10    11    12    13    14    15    16    17    18    19  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.